Brief: Passage Bio Reports Third Quarter 2024 Financial Results And Provides Recent Business Highlights

Passage Bio

13/11/2024 13:19

Nov 13 (Reuters) - Passage Bio Inc  PASG.O :
    * PASSAGE BIO REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
AND
PROVIDES RECENT BUSINESS HIGHLIGHTS
    * PASSAGE BIO: EXECUTION BACKED BY STRONG BALANCE SHEET,
WITH CASH
RUNWAY TO END OF Q2 2026
    * PASSAGE BIO: CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES
WERE $84.8 MILLION AS OF SEPTEMBER 30, 2024

Source text:  urn:newsml:reuters.com:*:nGNXMgmDF
Further company coverage:  PASG.O 

 ((Reuters.Briefs@thomsonreuters.com;))